Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Rolitetracycline Action Pathway (new)
Homo sapiens
Drug Action Pathway
Rolitetracycline, a broad-spectrum tetracycline antibiotic, is used for treatment when higher concentrations are required. Rolitetracycline passively diffuses through porin channels into bacterial cells and binds to the 30S ribosomal subunit. By binding to 30S subunit which prevents tRNA binding to mRNA ribosome complex and disrupting protein synthesis. Milk and dairy products should be avoided in order to optimize the absorption of rolitetracycline.
References
Rolitetracycline Pathway (new) References
Lashev L, Pashov D, Kanelov I: Species specific pharmacokinetics of rolitetracycline. Zentralbl Veterinarmed A. 1995 May;42(3):201-8. doi: 10.1111/j.1439-0442.1995.tb00371.x.
Pubmed: 8578898
SMITH L: ROLITETRACYCLINE, AN ANTIBIOTIC FOR PARENTERAL USE. (SYNTETRIN, VELACYCLINE). JAMA. 1964 Jan 11;187:141. doi: 10.1001/jama.1964.03060150065017.
Pubmed: 14066734
Wilcox RR: Rolitetracycline by injection and tetracycline phosphate complex by mouth given in a single session in the treatment of gonorrhoea in males. Acta Derm Venereol. 1970;50(2):154-6.
Pubmed: 4192321
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
No Proteins Present
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
No Proteins Present
Clear
Downloads
Settings